Skip to content Skip to footer
+44 7436 790706
Let’s Talk
Let’s Talk
Close
Hampton Genetics | Market Evaluation Report
Hampton Genetics Analysis

Hampton Genetics Evaluation

Commercial assessment of whole exome sequencing capabilities.
Request Full Audit View Summary Tables
Market Analysis

Broad Clinical Comparisons

The product performs well in terms of conditions tested. While priced as a premium offering, reducing unit costs through sequencing efficiency will unlock significant market share.

Commercial Assessment

Hampton's technological and pricing position in the global market
Pricing

Pricing Analysis

Hampton is currently one of the most expensive tests in the market. Pricing is driven by the choice to sequence the whole exome (WES). Competitors offering similar coverage at lower price points suggest that optimizing internal sequencing costs is the primary path to market competitiveness.

Technology

NGS Precision

Hampton uses Next-Generation Sequencing (NGS) as its foundation. By sequencing the full exome, it achieves market-leading depth. While clinical value for extremely rare conditions is high, the "Gold Standard" reagents and automation currently align with industry leaders.

AI Impact

VUS Interpretation

Hampton utilizes AI to predict the effect of Variants of Unknown Significance (VUS). This enables more accurate rare disease diagnostics than conventional screens. The clinical utility is maximized through automated data analysis that speeds up reporting times significantly.

Service Capabilities

The standard sample-to-result workflow for Hampton A and B products.
At-Home Collection

At-Home Collection

User Experience
  • Saliva/Blood Kit
  • In-line with Market
  • Clinic-free testing
Data Processing

Data Processing

Automation
  • Variant Filtering
  • AI Risk Scoring
  • Secure Data Storage
NGS Sequencing

NGS Sequencing

Core Technology
  • Library Preparation
  • Full Exon Screening
  • Zero Ethnic Bias
Counseling

Counseling

Patient Care
  • Actionable Results
  • Post-test Guidance
  • No-extra-cost Support
Inclusivity

Pan-Ethnic Diagnostic Utility

Hampton's use of Whole Exome Sequencing (WES) sequences the entire length of every exon, rather than just known common mutations. This is a crucial differentiator as it identifies population-specific variants often missed by European-centric targeted panels, ensuring equal diagnostic accuracy across all global ancestries.
Review Bias Mitigation Data
Go to Top